{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-007985","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.385072+00:00","generated_at":"2026-06-15T21:02:04.552287+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IRADIMED reports record Q1 revenue $15.5M; raises FY 2023 guidance","bullets":["Q1 revenue $15.5M (+25.7% YoY); GAAP diluted EPS $0.27, non-GAAP $0.30.","Operating income $4.0M, up 30% YoY; gross margin 75.7% vs 76.2%.","Paid special dividend of $1.05 per share during Q1.","Q2 2023 guidance: revenue $15.6-15.8M, non-GAAP EPS $0.30-0.32.","FY 2023 guidance raised: revenue $62-63.5M, non-GAAP EPS $1.26-1.35."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-007985","json":"https://secwatch.observer/filing/0001558370-23-007985.json","markdown":"https://secwatch.observer/filing/0001558370-23-007985.md","text":"https://secwatch.observer/filing/0001558370-23-007985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023007985/0001558370-23-007985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023007985/irmd-20230504x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T21:02:04.552287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"212732e02c4f652be1a4d5c6040b1f722ed517b6","claim":"IRADIMED CORP reported the second quarter of 2023 results: revenue $15.6 million to $15.8 million, EPS $0.27 to $0.29. Guidance initiated.","evidence_excerpt":"For the second quarter of 2023, the Company expects to report revenue of $15.6 million to $15.8 million, GAAP diluted earnings per share of $0.27 to $0.29, and non-GAAP diluted earnings per share of $0.30 to $0.32.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023007985/0001558370-23-007985-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter of 2023"},{"label":"Revenue","value":"$15.6 million to $15.8 million"},{"label":"EPS","value":"$0.27 to $0.29"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"b6ba571a9bf13e5b62b598b237979c0243ee1463","claim":"IRADIMED CORP reported the first quarter ended March 31, 2023 results: revenue $15.5 million, net income $3.4 million, EPS $0.27 per diluted share.","evidence_excerpt":"For the first quarter ended March 31, 2023, the Company reported over 25% year-over-year revenue growth to $15.5 million compared to $12.3 million for the first quarter of 2022. Net income was $3.4 million, or $0.27 per diluted share, compared to $2.5 million, or $0.20 per diluted share for the first quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023007985/0001558370-23-007985-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Revenue","value":"$15.5 million"},{"label":"Net income","value":"$3.4 million"},{"label":"EPS","value":"$0.27 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"b9e92408694f472aca4d94a77033079aced941c2","claim":"IRADIMED CORP reported full-year 2023 results: revenue $62 million to $63.5 million, EPS $1.13 to $1.21. Guidance raised.","evidence_excerpt":"The Company increased its full-year 2023 financial guidance and now expects to report revenue of $62 million to $63.5 million, GAAP diluted earnings per share of $1.13 to $1.21, and non-GAAP diluted earnings per share of $1.26 to $1.35.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023007985/0001558370-23-007985-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full-year 2023"},{"label":"Revenue","value":"$62 million to $63.5 million"},{"label":"EPS","value":"$1.13 to $1.21"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}